New findings may enhance PARP inhibitors therapy in breast cancer

[News]

Findings from a new study reveal that PARP inhibitors, an emerging class of drugs being studied in cancer clinical trials, may be enhanced by combining them with inhibitors targeting an oncogene...

More... (http://www.medicalnewstoday.com/releases/305262.php)